Skip to content
buyWeak

Garo H Armen bought $945 of PTIX

EXEC. CHAIR & PRINCIPAL OFF at Protagenic Therapeutics, Inc.\new. 2,700 shares at an average of $0.35, traded Aug 19, 2026, filed Aug 20, 2026.

Conviction score
28
Value
$945
2,700 shares
Holdings after
36,899
+8% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Chair
    +20
  • Trade size
    $945 at market
    0
  • Relative to holdings
    Holdings up 8%
    +3
  • Price context
    No price history yet
    0
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    5 buys in 90 days
    +5
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

PTIXOct 9, 2026 · close 0.77
Since filing Aug 20, 2026: +28.3%SPY +2.3% · excess +26.0%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001493152-26-039399, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Aug 19, 2026POpen-market purchase
COMMON STOCK
+2,700$0.35$94536,899Aug 20, 2026

Related signals

Other insiders at Protagenic Therapeutics, Inc.\new and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
31Weak
PTIXbuy
Protagenic Therapeutics, Inc.\new
Garo H Armen
EXEC. CHAIR & PRINCIPAL OFF
$13k
20,000 shares
+37%
31Weak
PTIXbuy
Protagenic Therapeutics, Inc.\new
Garo H Armen
EXEC. CHAIR & PRINCIPAL OFF
$9,811
16,634 shares
+45%
28Weak
PTIXbuy
Protagenic Therapeutics, Inc.\new
Garo H Armen
EXEC. CHAIR & PRINCIPAL OFF
$710
2,220 shares
+7%
25Weak
PTIXbuy
Protagenic Therapeutics, Inc.\new
Garo H Armen
EXEC. CHAIR & PRINCIPAL OFF
$151
685 shares
+2%
28Weak
PTIXbuy
Protagenic Therapeutics, Inc.\new
Garo H Armen
EXEC. CHAIR & PRINCIPAL OFF
$1,294
5,000 shares
+19%
28Weak
PTIXbuy
Protagenic Therapeutics, Inc.\new
Garo H Armen
EXEC. CHAIR & PRINCIPAL OFF.
$4,806
26,291 shares
-
46Moderate
PTIXbuy
Protagenic Therapeutics, Inc.\new
Alexander K. Arrow
Chief Financial Officer
$6,480
8,000 shares
+21%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Garo H Armen bought $945 of PTIX | InsiderTell